Hims & Hers Buys Lab to Expand Into At-Home Blood Testing (1)

Feb. 19, 2025, 3:01 PM UTC

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of a home blood-testing company.

The telehealth provider purchased Sigmund NJ LLC, which uses a US-approved device for home testing of hormones, cholesterol and other markers of health, according to a statement on Wednesday. New Jersey-based Sigmund markets its services as Trybe Labs. Terms of the deal weren’t disclosed.

Hundreds of thousands of Americans have turned to Hims and other telehealth companies for copies of weight-loss drugs after struggling to access brand-name versions made by Novo Nordisk A/S and ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.